Tag: growth

SINGAPORE, July 3, 2025 /PRNewswire/ -- Vistra, a leading provider of essential business solutions that help organisations to invest and grow efficiently and compliantly...

LEATHERHEAD, England, July 3, 2025 /PRNewswire/ -- MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has received its CE mark,...

TAMPERE, Finnland, July 03, 2025 (GLOBE NEWSWIRE) -- Die von Merus Power an Lappeenranta, Finnland, gelieferte Energiespeicheranlage wurde fertiggestellt und am 15. Mai 2025 in Betrieb genommen. Eigentümer des Energiespeichers ist ein Joint Venture zwischen dem Clean Energy Evergreen Fund von Ardian und dem lokalen Energieversorger Lappeenrannan Energia. Mit einer Leistung von rund 38 Megawatt und einer Energiemenge von 43 Megawattstunden ist er einer der größten Energiespeicher, die auf dem finnischen Strommarkt im Einsatz sind. Die Fertigstellung des Projekts ist für Merus Power von großer Bedeutung, da es sich um die größte von dem Unternehmen hergestellte Energiespeicheranlage handelt.

EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across Europe...

TAMPERE, Finland, July 03, 2025 (GLOBE NEWSWIRE) -- The energy storage facility delivered by Merus Power to Lappeenranta, Finland, has been completed and put into market use on 15 May 2025. The energy storage facility is owned by a joint venture between Ardian’s Clean Energy Evergreen Fund and the local energy provider Lappeenrannan Energia. It is one of the largest energy storage facilities in use on the Finnish electricity market with an output of approximately 38 megawatts and energy of 43 megawatt hours. The completion of the project is significant for Merus Power, as it is the largest energy storage facility manufactured by the company.

LUXEMBOURG, July 3, 2025 /PRNewswire/ -- Global alternative lender Bizcap has announced its launch into Luxembourg, establishing its first operational footprint in continental Europe. Following its...

Bang & Olufsen ended the year with 4% revenue growth in Q4 and a 1% decline in local currencies for the full year, bringing total revenue to DKK 2.6bn. The gross margin continued to increase, reaching a record-high 55.8% in Q4, and 55.0% at year end. For the full year, the EBIT margin before special items was 1.0%, and free cash flow amounted to DKK 16m. Overall, the results were in line with plans and aligned with the outlook for the year.

Reliable in use, removable when needed – Next-gen adhesive solutions that can be precisely and residue-free removedInnovation hub with impact – Accelerating customer-specific developments...

Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs...

Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs...

STOCKHOLM, SWEDEN – July 3, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces an update from Organon on the development of the drug candidate OG-6219, acquired by Organon through its acquisition of Forendo Pharma in 2021. Following results from a Phase 2 clinical study with OG-6219, Organon plans to discontinue the clinical development of the drug candidate.